Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Silence Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLN.
You can purchase shares of Silence Therapeutics (NASDAQ:SLN) through any online brokerage.
Other companies in Silence Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Korro Bio (NASDAQ:KRRO).
Silence Therapeutics has a consensus price target of $37.00.
The stock price for Silence Therapeutics (NASDAQ: SLN) is $3.18 last updated April 17, 2025 at 6:05 PM EDT.
There are no upcoming dividends for Silence Therapeutics.
Silence Therapeutics’s Q1 earnings are confirmed for Thursday, May 15, 2025.
There is no upcoming split for Silence Therapeutics.
Silence Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.